Targeting catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutations

Targeting β-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutations

02:46 EDT 4 Apr 2019 | Nature Publishing

More From BioPortfolio on "Targeting β-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutations"